GMP compliance – Page 8

How to Conduct Risk-Based Ongoing Stability Batch Selection

Guidelines for Addressing Ongoing Stability Program Gaps Pharmaceutical professionals often face challenges in ongoing stability programs that can lead to regulatory non-compliance and compromised product quality. In this article, we…

Matrixing Strategy for High-Volume Stability Programs: Practical Controls

Understanding and Addressing Bracketing and Matrixing Misuse in High-Volume Stability Programs In the realm of pharmaceutical stability testing, the usage of bracketing and matrixing strategies is essential for validating product…

Ongoing Stability Gaps After Raw Material Supplier Changes

Troubleshooting Ongoing Stability Gaps Following Changes in Raw Material Suppliers Changes in raw material suppliers can introduce significant risks to pharmaceutical manufacturing stability, potentially leading to ongoing stability program gaps.…

Bracketing Errors in Liquid Oral Dosage Form Stability Studies

Addressing Errors in Stability Studies of Liquid Oral Dosage Forms Using Bracketing and Matrixing As pharmaceutical professionals engaged in stability studies, we often encounter issues arising from the improper application…

How to Review Ongoing Stability Data During Product Quality Review

Reviewing Ongoing Stability Data for Effective Quality Management Ongoing stability program gaps can lead to significant issues in pharmaceutical manufacturing, potentially compromising product efficacy and regulatory compliance. This article provides…

Why Regulators Reject Weak ICH Q1D Justifications

Understanding and Resolving Issues with ICH Q1D Justifications in Bracketing and Matrixing In today’s complex pharmaceutical landscape, compliance with regulatory frameworks like ICH Q1D is critical for ensuring the validity…

Ongoing Stability Pull Window Deviations and Corrective Actions

How to Address Ongoing Stability Program Gaps Effectively In pharmaceutical manufacturing, maintaining the integrity of stability studies is crucial for ensuring product quality and compliance with regulatory guidelines. Deviations within…

Ongoing Stability Pull Window Deviations and Corrective Actions

Managing Deviations in Ongoing Stability Programs: A Step-by-Step Approach Pharmaceutical manufacturers often encounter challenges related to ongoing stability program gaps, impacting regulatory compliance and product integrity. This piece will empower…

Bracketing and Matrixing Compliance Checklist for QA Review

Addressing Compliance Issues Related to Bracketing and Matrixing in Quality Assurance In the realm of pharmaceutical stability studies, the methodologies of bracketing and matrixing remain highly relevant but are often…

How to Maintain Ongoing Stability Inventory and Sample Accountability

Essential Steps for Managing Stability Program Gaps in Pharmaceutical Manufacturing Maintaining an effective ongoing stability program is crucial for pharmaceutical manufacturers to ensure product quality and compliance with regulatory standards.…

How to Maintain Ongoing Stability Inventory and Sample Accountability

Strategies for Managing Ongoing Stability Program Gaps in Pharmaceuticals In the highly regulated pharmaceutical industry, maintaining the integrity of stability data is paramount for ensuring product quality and safety. Gaps…

How to Create a Defensible Matrixing Pull Schedule

Strategies to Address Bracketing and Matrixing Misuse in Stability Studies The pharmaceutical industry faces significant challenges when implementing stability studies, particularly concerning bracketing and matrixing methodologies. Frequent errors in creating…